Therapeutic surveillance of anti-epileptic drugs. Determination of dosage regimen and monitoring of treatment
Kumps, A.
Acta Neurologica Belgica 82(4): 209-214
1982
ISSN/ISBN: 0300-9009 PMID: 6814159 Document Number: 183368
Document emailed within 1 workday
Related Documents
Bärtschi, E.; Woringer, V.; Chandesais, P. 1978: Blood monitoring for anti-epileptic drugs during treatment of epilepsy Revue Medicale de la Suisse Romande 98(4): 181-197Borgheresi, S.; Zammarchi, E.; Buti, D.; Luti, E.; Bardini, M.R. 1977: Usefulness of the determination of blood levels of anti-epileptic drugs in pediatrics La Pediatria 85(2): 22-36
Ritschel, W.A.; Banarer, M.; Lau-Chang, E.F. 1977: Computer-calculated kanamycin dosage regimen and monitoring International Journal of Clinical Pharmacology and Biopharmacy 15(3): 121-125
Chino, H.; Hagiwara, E.; Sekine, A.; Kitamura, H.; Baba, T.; Shinohara, T.; Komatsu, S.; Ogura, T. 2016: [compliance Rate of Standard Treatment Regimen and Optimal Dose of Anti-Tuberculosis Drugs in Late Elderly Patients with Pulmonary Tuberculosis Kekkaku: 91(5): 495-502
Miller, R.; Nowosiad, D.; Warnes, D.M.; De Wet, J.M. 1982: The role of therapeutic drug monitoring in the care of epileptic patients South African Medical Journal 62(15): 512-515
Campistol, J. 2002: Teratogenic effects of epilepsy and anti epileptic drugs Revista de Neurologia 35(Suppl 1): S135-S143
Chapman, A.; Meldrum, B. 1991: Excitatory amino acids in epilepsy and novel anti-epileptic drugs Epilepsy Research. Suppl 3: 39-48
Denooz, R.; Charlier, C. 2010: Sulfonylureas dosage: from therapeutic monitoring to differential diagnosis of hyperinsulinism Revue Medicale de Liege 65(9): 493-497
He, Y.; Zhao, Y.; Guo, Z.; Li, X. 1997: Pharmacokinetic evaluation of the dosage regimen evaluation of drugs obeying first order clearance kinetics: intravenous infusion administration Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 14(1): 61-63
Levernieux, J. 1974: Variation and changes in the dosage of anti-inflammatory drugs in rheumatology Semaine des Hopitaux. Therapeutique 50(7-8): 497-500
Szczechowski, L.; Marczewska, E. 1987: Role of membrane receptors in the pathogenesis of epilepsy and in the mechanism of action of anti-epileptic drugs Polski Tygodnik Lekarski 42(16): 485-488
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Szczechowski, L.; Lenart-Grabowska, M.; Marczewska, E. 1989: The role of adenosine cyclic monophosphate (c-AMP) in the pathogenesis of epilepsy and the mechanism of the action of anti-epileptic drugs Wiadomosci Lekarskie 42(13-15): 881-883
Jagiełło-Wójtowicz, E.; Kleinrok, Z.; Feldo, M.; Chodkowska, A.; Nowicky, J.W. 1992: Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice Drugs under Experimental and Clinical Research 18(Suppl): 107-109
Korany, M.A.; Wahbi, A.M.; Elsayed, M.A.; Mandour, S. 1984: Application of first derivative spectrophotometry to the determination of certain drugs in single component dosage forms Il Farmaco; Edizione Pratica 39(7): 243-252
Meyer, B.; Traunmüller, F.; Hamwi, A.; Hollenstein, U.M.; Locker, G.J.; Sperr, W.R.; Staudinger, T.; Thalhammer-Scherrer, R.; Burgmann, H.; Thalhammer, F. 2004: Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage International Journal of Clinical Pharmacology and Therapeutics 42(10): 556-560
Simonin, R.; San Marco, J.L.; Heim, M.; Brindisi, G. 1981: Treatment of primary hypothyroidism in adults : dosage schedule and biological surveillance La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 57(37-38): 1480-1487
Grzesiak, M.; Beszłej, J.A.; Szewczuk-Bogusławska, M. 2003: Therapeutic monitoring of tricyclic antidepressant drugs Psychiatria Polska 37(5): 825-837
Schmalbach, K.; Helmke, K.; Heinen, D.; Müller, S.; Suchatzki, B.U. 1973: Moxisylyt as a therapeutic agent in epileptic disturbances. Experimental study on normal cats and animals with chronic epileptic processes Arzneimittel-Forschung 23(12): 1734-1737
Mahadev, B.; Kumar, P.; Agarwal, S.P.; Chauhan, L.S.; Srikantaramu, N. 2005: Surveillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa Indian Journal of Tuberculosis 52(1): 5-10